SCHEMBL19682403

SCHEMBL19682403

COC(=O)c1cc(S(=O)(=O)Cl)c(C#N)cc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
GAA P10253 2/20 0.42
LMNA P02545 2/20 0.41
CA12 O43570 5/20 0.41
CA1 P00915 5/20 0.41
CA2 P00918 5/20 0.41
CA9 Q16790 5/20 0.41
ALDH1A1 P00352 2/20 0.39
TSHR P16473 1/20 0.39
KDM4E B2RXH2 2/20 0.39
RXFP1 Q9HBX9 1/20 0.39
HPGD P15428 2/20 0.38
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
CA3 P07451 1/20 0.36
CA4 P22748 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19682941 0.84 GAA (0.41) MAPTNPSR1GAALMNACA1
SCHEMBL29628681 0.84 GAA (0.41) MAPTNPSR1GAALMNACA1
SCHEMBL19682572 0.80 ALDH1A1 (0.41) MAPTCA12CA1CA2CA9
SCHEMBL8576931 0.79 CA1 (0.50) CA12CA1CA2CA9CA3
SCHEMBL18982096 0.78 MAPT (0.45) MAPTNPSR1GAALMNACA12
SCHEMBL2775679 0.78 GAA (0.49) MAPTNPSR1GAALMNAALDH1A1
SCHEMBL19682402 0.78 GAA (0.44) MAPTNPSR1GAALMNAALDH1A1
SCHEMBL2772574 0.78 GAA (0.44) MAPTNPSR1GAALMNAALDH1A1
SCHEMBL8576788 0.77 ALDH1A1 (0.43) MAPTNPSR1GAALMNAALDH1A1
SCHEMBL11255716 0.77 GAA (0.49) MAPTNPSR1GAALMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10889555-B2 Sulfonamide compound or salt thereof TAIHO PHARMACEUTICAL CO., LTD. (JP) 2021-01-12 US disclosed
US-20200405697-A1 Antitumor Agent TAIHO PHARMACEUTICAL CO., LTD. (JP) 2020-12-31 US disclosed
US-20200399235-A1 Sulfonamide Compound or Salt Thereof TAIHO PHARMACEUTICAL CO., LTD. (JP) 2020-12-24 US disclosed
EP-3718545-A1 ANTITUMOR AGENT Taiho Pharmaceutical Co., Ltd. (JP) 2020-10-07 EP disclosed
US-20200157066-A1 Sulfonamide Compound or Salt Thereof TAIHO PHARMACEUTICAL CO., LTD. (JP) 2020-05-21 US disclosed
EP-3466934-A1 SULFONAMIDE COMPOUND OR SALT THEREOF Taiho Pharmaceutical Co., Ltd. (JP) 2019-04-10 EP disclosed
WO-2017209155-A1 SULFONAMIDE COMPOUND OR SALT THEREOF 大鵬薬品工業株式会社 2017-12-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200399235-A1 Sulfonamide Compound or Salt Thereof RNASEH1, SNRPA1, RRM2 MAPT 4312/4885NPSR1 353/4885GAA 2150/4885
US-20200157066-A1 Sulfonamide Compound or Salt Thereof RNASEH1, SNRPA1, RRM2 MAPT 4312/4885NPSR1 353/4885GAA 2150/4885
US-10889555-B2 Sulfonamide compound or salt thereof RNASEH1, SNRPA1, RRM2 MAPT 4312/4885NPSR1 353/4885GAA 2150/4885
US-20200405697-A1 Antitumor Agent HNRNPR, RRM2, RRM2B MAPT 4815/4885NPSR1 184/4885GAA 2949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.